To determine whether the differences in the levels of circulating CD133+CXCR4+CD34- stem cells observed in mild and severe DMD patients correlate to a different myo-endothelial potential of these cells, myogenic and angiogenic assays were performed. The gene discussed is CD34; the disease is Duchenne muscular dystrophy.